Abstract |
Hypoxic regions limit the radiocontrollability of head and neck carcinomas. Whether or not combinations of plasmid/ liposome mediated overexpression of normal tissue protective manganese superoxide dismutase (MnSOD), cetuximab ( C225), and the hypoxic cytotoxin tirapazamine (TPZ) enhanced radiotherapeutic effects was tested in a CAL-33 orthotopic mouse cheek tumor model. The tumor volume continued to increase in the control (untreated) mice, with a ninefold increase by 10 days when the tumors exceeded 2 cm(3). The mice receiving 14 Gy only showed reduced tumor growth to 3.1+/-0.1 fold at day 10. The mice receiving MnSOD-PL, C225, TPZ plus 14 Gy had the best outcome with 0.7+/-0.1 fold increase in tumor volume by 10 days (p=0.015) compared to irradiation only. The addition of MnSOD-PL, TPZ, and C225 to irradiation optimized the therapeutic ratio for the local control of hypoxic region-containing CAL-33 orthotopic tumors.
|
Authors | Michael W Epperly, Stephen Y Lai, Anthony J Kanai, Neal Mason, Brian Lopresi, Tracey Dixon, Darcy Franicola, Yunyun Niu, William R Wilson, Joel S Greenberger |
Journal | In vivo (Athens, Greece)
(In Vivo)
2010 Jan-Feb
Vol. 24
Issue 1
Pg. 1-8
ISSN: 0258-851X [Print] Greece |
PMID | 20133969
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Liposomes
- Radiation-Sensitizing Agents
- Triazines
- Tirapazamine
- Nitric Oxide
- Superoxide Dismutase
- Cetuximab
|
Topics |
- Animals
- Antibodies, Monoclonal
(administration & dosage)
- Antibodies, Monoclonal, Humanized
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Carcinoma, Squamous Cell
(metabolism, pathology, therapy)
- Cell Line, Tumor
- Cetuximab
- Dose-Response Relationship, Radiation
- Genetic Therapy
- Humans
- Liposomes
- Mice
- Mice, Nude
- Mouth Neoplasms
(metabolism, pathology, therapy)
- Nitric Oxide
(metabolism)
- Radiation-Sensitizing Agents
(administration & dosage)
- Radiotherapy, Adjuvant
- Superoxide Dismutase
(genetics)
- Tirapazamine
- Triazines
(administration & dosage)
- Xenograft Model Antitumor Assays
|